Big Names Weigh In

While personal genomics companies say their tests have predictive value and will be helpful in health and wellness, The Economist asks what David Altshuler, Craig Venter, Russ Altman, George Church, and others think. Altshuler says that companies encourage people to read too deeply into their genomes -- he refused to have his sequenced -- and that he's worried about a backlash.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.